{"entity":{"type":"insider","cik":"0001352961","url":"/insider/0001352961","json_url":"/insider/0001352961.json","name":"CROWLEY Richard","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":16,"first":"2006-04-24","last":"2013-10-17","span_basis":"filed_date"},"name_variants":[{"name":"CROWLEY Richard","source":"filing","n_filings":16,"first_seen":"2006-04-24","last_seen":"2013-10-17"}],"transactions":[{"id":4738417,"accession":"0001181431-13-054157","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-054157","line_url":"/filing/0001181431-13-054157","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001352961","owner_name":"CROWLEY Richard","owner_display_name":"CROWLEY Richard","owner_url":"/insider/0001352961","role":"Officer (Co-President and COO)","role_mark":"O","role_mark_label":"Officer (Co-President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Co-President and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":113740.0,"shares_display":"113,740","price_per_share":0.07595091876208898,"price_display":"0.08","price_state":"stated","total_value":8638.6575,"total_display":"8,638.66","total_whole":"8,639","shares_owned_after":171750.0,"shares_owned_after_display":"171,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-15","filed_date":"2013-10-17","scope":"insider","n_lines":2},{"id":4449213,"accession":"0001181431-13-024354","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-024354","line_url":"/filing/0001181431-13-024354#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001352961","owner_name":"CROWLEY Richard","owner_display_name":"CROWLEY Richard","owner_url":"/insider/0001352961","role":"Officer (EVP, Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2485.0,"shares_display":"2,485","price_per_share":0.74,"price_display":"0.74","price_state":"stated","total_value":1838.9,"total_display":"1,838.90","total_whole":"1,839","shares_owned_after":285490.0,"shares_owned_after_display":"285,490","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-30","filed_date":"2013-05-01","scope":"insider"},{"id":5327858,"accession":"0001181431-13-007057","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-007057","line_url":"/filing/0001181431-13-007057","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001352961","owner_name":"CROWLEY Richard","owner_display_name":"CROWLEY Richard","owner_url":"/insider/0001352961","role":"Officer (EVP, Biopharmaceutical Ops)","role_mark":"O","role_mark_label":"Officer (EVP, Biopharmaceutical Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Biopharmaceutical Ops","security_title":"Common Stock $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48900.0,"shares_display":"48,900","price_per_share":1.0345398773006136,"price_display":"1.03","price_state":"stated","total_value":50589.0,"total_display":"50,589.00","total_whole":"50,589","shares_owned_after":287975.0,"shares_owned_after_display":"287,975","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-04","filed_date":"2013-02-06","scope":"insider","n_lines":2},{"id":5100231,"accession":"0001181431-13-006299","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-006299","line_url":"/filing/0001181431-13-006299#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001352961","owner_name":"CROWLEY Richard","owner_display_name":"CROWLEY Richard","owner_url":"/insider/0001352961","role":"Officer (EVP, Biopharmaceutical Ops)","role_mark":"O","role_mark_label":"Officer (EVP, Biopharmaceutical Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Biopharmaceutical Ops","security_title":"Common Stock $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2415.0,"shares_display":"2,415","price_per_share":1.02,"price_display":"1.02","price_state":"stated","total_value":2463.3,"total_display":"2,463.30","total_whole":"2,463","shares_owned_after":336875.0,"shares_owned_after_display":"336,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-31","filed_date":"2013-02-04","scope":"insider"},{"id":3376090,"accession":"0001181431-12-057115","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-057115","line_url":"/filing/0001181431-12-057115#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001352961","owner_name":"CROWLEY Richard","owner_display_name":"CROWLEY Richard","owner_url":"/insider/0001352961","role":"Officer (EVP, Biopharmaceutical Ops)","role_mark":"O","role_mark_label":"Officer (EVP, Biopharmaceutical Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Biopharmaceutical Ops","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2010.0,"shares_display":"2,010","price_per_share":1.45,"price_display":"1.45","price_state":"stated","total_value":2914.5,"total_display":"2,914.50","total_whole":"2,915","shares_owned_after":339290.0,"shares_owned_after_display":"339,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-10-31","filed_date":"2012-11-06","scope":"insider"},{"id":3439345,"accession":"0001181431-12-043397","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-043397","line_url":"/filing/0001181431-12-043397#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001352961","owner_name":"CROWLEY Richard","owner_display_name":"CROWLEY Richard","owner_url":"/insider/0001352961","role":"Officer (EVP, Biopharma Operatiotions)","role_mark":"O","role_mark_label":"Officer (EVP, Biopharma Operatiotions)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Biopharma Operatiotions","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":0.62,"price_display":"0.62","price_state":"stated","total_value":1550.0,"total_display":"1,550.00","total_whole":"1,550","shares_owned_after":341300.0,"shares_owned_after_display":"341,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-02","filed_date":"2012-08-03","scope":"insider"},{"id":2805521,"accession":"0001181431-12-026762","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-026762","line_url":"/filing/0001181431-12-026762#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001352961","owner_name":"CROWLEY Richard","owner_display_name":"CROWLEY Richard","owner_url":"/insider/0001352961","role":"Officer (EVP Biopharmaceutical Operatio)","role_mark":"O","role_mark_label":"Officer (EVP Biopharmaceutical Operatio)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Biopharmaceutical Operatio","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9200.0,"shares_display":"9,200","price_per_share":2.35,"price_display":"2.35","price_state":"stated","total_value":21620.0,"total_display":"21,620.00","total_whole":"21,620","shares_owned_after":343800.0,"shares_owned_after_display":"343,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-01","filed_date":"2012-05-01","scope":"insider"},{"id":9188486,"accession":"0001181431-11-057427","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-057427","line_url":"/filing/0001181431-11-057427#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001352961","owner_name":"CROWLEY Richard","owner_display_name":"CROWLEY Richard","owner_url":"/insider/0001352961","role":"Officer (EVP Biopharmaceutical Operatio)","role_mark":"O","role_mark_label":"Officer (EVP Biopharmaceutical Operatio)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Biopharmaceutical Operatio","security_title":"Common Stock, $.01 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":2.53,"price_display":"2.53","price_state":"stated","total_value":7590.0,"total_display":"7,590.00","total_whole":"7,590","shares_owned_after":103000.0,"shares_owned_after_display":"103,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-21","filed_date":"2011-11-22","scope":"insider"},{"id":3564881,"accession":"0001104659-08-069272","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-08-069272","line_url":"/filing/0001104659-08-069272#line-2","is_derivative":false,"issuer_cik":"0000765258","issuer_name":"IMCLONE SYSTEMS INC","issuer_ticker":"IMCL","issuer_name_source":null,"issuer_url":"/issuer/0000765258","owner_cik":"0001352961","owner_name":"CROWLEY Richard","owner_display_name":"CROWLEY Richard","owner_url":"/insider/0001352961","role":"Officer (SVP, Biopharmaceutical Ops)","role_mark":"O","role_mark_label":"Officer (SVP, Biopharmaceutical Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Biopharmaceutical Ops","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11957.0,"shares_display":"11,957","price_per_share":68.72,"price_display":"68.72","price_state":"stated","total_value":821685.04,"total_display":"821,685.04","total_whole":"821,685","shares_owned_after":1774.0,"shares_owned_after_display":"1,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-03","filed_date":"2008-11-07","scope":"insider"},{"id":3742106,"accession":"0001104659-08-056889","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-08-056889","line_url":"/filing/0001104659-08-056889#line-2","is_derivative":false,"issuer_cik":"0000765258","issuer_name":"IMCLONE SYSTEMS INC","issuer_ticker":"IMCL","issuer_name_source":null,"issuer_url":"/issuer/0000765258","owner_cik":"0001352961","owner_name":"CROWLEY Richard","owner_display_name":"CROWLEY Richard","owner_url":"/insider/0001352961","role":"Officer (SVP, Biopharmaceutical Ops)","role_mark":"O","role_mark_label":"Officer (SVP, Biopharmaceutical Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Biopharmaceutical Ops","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11957.0,"shares_display":"11,957","price_per_share":64.4,"price_display":"64.40","price_state":"stated","total_value":770030.8,"total_display":"770,030.80","total_whole":"770,031","shares_owned_after":1774.0,"shares_owned_after_display":"1,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-02","filed_date":"2008-09-04","scope":"insider"},{"id":2659310,"accession":"0001104659-08-049255","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-08-049255","line_url":"/filing/0001104659-08-049255#line-4","is_derivative":false,"issuer_cik":"0000765258","issuer_name":"IMCLONE SYSTEMS INC","issuer_ticker":"IMCL","issuer_name_source":null,"issuer_url":"/issuer/0000765258","owner_cik":"0001352961","owner_name":"CROWLEY Richard","owner_display_name":"CROWLEY Richard","owner_url":"/insider/0001352961","role":"Officer (SVP, Biopharmaceutical Ops)","role_mark":"O","role_mark_label":"Officer (SVP, Biopharmaceutical Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Biopharmaceutical Ops","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":64.16,"price_display":"64.16","price_state":"stated","total_value":962400.0,"total_display":"962,400.00","total_whole":"962,400","shares_owned_after":1774.0,"shares_owned_after_display":"1,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-31","filed_date":"2008-08-01","scope":"insider"},{"id":7466745,"accession":"0001104659-07-084555","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-07-084555","line_url":"/filing/0001104659-07-084555","is_derivative":false,"issuer_cik":"0000765258","issuer_name":"IMCLONE SYSTEMS INC","issuer_ticker":"IMCL","issuer_name_source":null,"issuer_url":"/issuer/0000765258","owner_cik":"0001352961","owner_name":"CROWLEY Richard","owner_display_name":"CROWLEY Richard","owner_url":"/insider/0001352961","role":"Officer (SVP, Biopharmaceutical Ops)","role_mark":"O","role_mark_label":"Officer (SVP, Biopharmaceutical Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Biopharmaceutical Ops","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9150.0,"shares_display":"9,150","price_per_share":42.65,"price_display":"42.65","price_state":"stated","total_value":390247.5,"total_display":"390,247.50","total_whole":"390,248","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-19","filed_date":"2007-11-21","scope":"insider","n_lines":2},{"id":2659292,"accession":"0001104659-08-049255","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-08-049255","line_url":"/filing/0001104659-08-049255#line-1","is_derivative":false,"issuer_cik":"0000765258","issuer_name":"IMCLONE SYSTEMS INC","issuer_ticker":"IMCL","issuer_name_source":null,"issuer_url":"/issuer/0000765258","owner_cik":"0001352961","owner_name":"CROWLEY Richard","owner_display_name":"CROWLEY Richard","owner_url":"/insider/0001352961","role":"Officer (SVP, Biopharmaceutical Ops)","role_mark":"O","role_mark_label":"Officer (SVP, Biopharmaceutical Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Biopharmaceutical Ops","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11957.0,"shares_display":"11,957","price_per_share":64.16,"price_display":"64.16","price_state":"stated","total_value":767161.12,"total_display":"767,161.12","total_whole":"767,161","shares_owned_after":1774.0,"shares_owned_after_display":"1,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-19","filed_date":"2008-08-01","scope":"insider"},{"id":4381536,"accession":"0000765258-06-000050","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000765258-06-000050","line_url":"/filing/0000765258-06-000050#line-2","is_derivative":false,"issuer_cik":"0000765258","issuer_name":"IMCLONE SYSTEMS INC","issuer_ticker":"IMCL","issuer_name_source":null,"issuer_url":"/issuer/0000765258","owner_cik":"0001352961","owner_name":"CROWLEY Richard","owner_display_name":"CROWLEY Richard","owner_url":"/insider/0001352961","role":"Officer (SVP, Biopharmaceutical Ops)","role_mark":"O","role_mark_label":"Officer (SVP, Biopharmaceutical Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Biopharmaceutical Ops","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":38.6756,"price_display":"38.68","price_state":"stated","total_value":38675.6,"total_display":"38,675.60","total_whole":"38,676","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-07-03","filed_date":"2006-07-05","scope":"insider"},{"id":3278398,"accession":"0000765258-06-000047","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000765258-06-000047","line_url":"/filing/0000765258-06-000047#line-2","is_derivative":false,"issuer_cik":"0000765258","issuer_name":"IMCLONE SYSTEMS INC","issuer_ticker":"IMCL","issuer_name_source":null,"issuer_url":"/issuer/0000765258","owner_cik":"0001352961","owner_name":"CROWLEY Richard","owner_display_name":"CROWLEY Richard","owner_url":"/insider/0001352961","role":"Officer (SVP, Biopharmaceutical Ops)","role_mark":"O","role_mark_label":"Officer (SVP, Biopharmaceutical Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Biopharmaceutical Ops","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":39.84,"price_display":"39.84","price_state":"stated","total_value":39840.0,"total_display":"39,840.00","total_whole":"39,840","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-06-01","filed_date":"2006-06-05","scope":"insider"},{"id":3716389,"accession":"0000765258-06-000042","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000765258-06-000042","line_url":"/filing/0000765258-06-000042#line-2","is_derivative":false,"issuer_cik":"0000765258","issuer_name":"IMCLONE SYSTEMS INC","issuer_ticker":"IMCL","issuer_name_source":null,"issuer_url":"/issuer/0000765258","owner_cik":"0001352961","owner_name":"CROWLEY Richard","owner_display_name":"CROWLEY Richard","owner_url":"/insider/0001352961","role":"Officer (SVP, Biopharmaceutical Ops)","role_mark":"O","role_mark_label":"Officer (SVP, Biopharmaceutical Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Biopharmaceutical Ops","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":35.96,"price_display":"35.96","price_state":"stated","total_value":35960.0,"total_display":"35,960.00","total_whole":"35,960","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-05-01","filed_date":"2006-05-03","scope":"insider"},{"id":4530301,"accession":"0000765258-06-000038","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000765258-06-000038","line_url":"/filing/0000765258-06-000038#line-2","is_derivative":false,"issuer_cik":"0000765258","issuer_name":"IMCLONE SYSTEMS INC","issuer_ticker":"IMCL","issuer_name_source":null,"issuer_url":"/issuer/0000765258","owner_cik":"0001352961","owner_name":"CROWLEY Richard","owner_display_name":"CROWLEY Richard","owner_url":"/insider/0001352961","role":"Officer (SVP, Biopharmaceutical Ops)","role_mark":"O","role_mark_label":"Officer (SVP, Biopharmaceutical Ops)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Biopharmaceutical Ops","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":35000.0,"total_display":"35,000.00","total_whole":"35,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-04-21","filed_date":"2006-04-24","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":20,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":19,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":20},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000722104","name":"SAVIENT PHARMACEUTICALS INC","url":"/issuer/0000722104","role":"Officer (Co-President and COO)","n_filings":8,"first_seen":"2011-11-22","last_seen":"2013-10-17"},{"type":"issuer","type_label":"ISSUER","cik":"0000765258","name":"IMCLONE SYSTEMS INC","url":"/issuer/0000765258","role":"Officer (SVP, Biopharmaceutical Ops)","n_filings":8,"first_seen":"2006-04-24","last_seen":"2008-11-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001352961","retrieved_at":"2026-08-24T21:26:26+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}